Ntagi

Ntagi News

NTAGI to discuss whether to allow early administration of precaution COVID dose to those travelling abroad
India

NTAGI to discuss whether to allow early administration of precaution COVID dose to those travelling abroad

The National Technical Advisory Group on Immunisation (NTAGI) may also review the data on COVID-19 vaccines for the 5-12 age group

First dose of Sputnik V to be given as booster to those vaccinated with Russian vaccine, NTAGI recommends
Health

First dose of Sputnik V to be given as booster to those vaccinated with Russian vaccine, NTAGI recommends

The two doses of Sputnik V vaccine have separate compositions -- the first dose contains a recombinant adenovirus type 26 (rAd26-S) and the second dose a recombinant adenovirus 5 (rAd5-S)

Why India's vaccine advisory body recommends reducing second-dose gap for Covishield
India

Why India's vaccine advisory body recommends reducing second-dose gap for Covishield

The National Technical Advisory Group on Immunisation has recommended that the gap between the first and second dose of Covishield should be reduced to eight to 16 weeks, from the current gap of 12 to 16

Union Budget 2022: Why Centre has reduced COVID-19 vaccine budget to Rs 5,000 crore
India

Union Budget 2022: Why Centre has reduced COVID-19 vaccine budget to Rs 5,000 crore

Experts are of the opinion that the reduction in allocation of funds hints that the Centre has done its job of providing free vaccines across the country and people may have to shell out for booster shots

Gap in our understanding of the science behind COVID-19 booster dose, says vaccine panel chief
Health

Gap in our understanding of the science behind COVID-19 booster dose, says vaccine panel chief

We must understand that our understanding of Omicron is still evolving and it will take another two to three weeks to derive any concrete understanding, Dr NK Arora said

No need for boosters, two jabs of vaccine enough to fight COVID, says NTAGI member
India

No need for boosters, two jabs of vaccine enough to fight COVID, says NTAGI member

Dr Jayaprakash Muliyil said NTAGI members have been deliberating over the issue of launching booster doses in India and another meeting is slated to happen next week

Looking into whether COVID-19 booster doses needed, Centre tells Delhi HC
India

Looking into whether COVID-19 booster doses needed, Centre tells Delhi HC

Centre told the court that the current knowledge about the duration of immunity offered by COVID-19 vaccines in India is limited and will clearly be known only over a period of time

NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised
India

NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised

A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is presumed to have declined

Has India reached the stage of assured and sustainable COVID-19 vaccine supply?
India

Has India reached the stage of assured and sustainable COVID-19 vaccine supply?

When it comes to vaccine supply, India is currently in a comfortable position. However, the coronavirus pandemic is not over yet

No scientific evidence to support need for booster vaccine dose against COVID-19, says ICMR chief
India

No scientific evidence to support need for booster vaccine dose against COVID-19, says ICMR chief

According to sources, the booster dose issue is likely to be discussed in the next meeting of the National Technical Advisory Group on Immunisation in India

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October
India

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October

The government is aiming to roll out India’s first approved vaccine for kids aged 12 years and above on 2 October, the birthday of Mahatma Gandhi

Reducing gap between two doses of Covishield being considered, say sources; Centre denies reports
India

Reducing gap between two doses of Covishield being considered, say sources; Centre denies reports

In May, the Centre further extended the gap between two doses of Covishield from 6-8 weeks to 12-16 weeks and said it was based on scientific evidence

Centre increases gap between Covishield doses to 12-16 weeks: All you need to know
India

Centre increases gap between Covishield doses to 12-16 weeks: All you need to know

This is the third time in three months that the Central Government has widened the intervals between Covishield doses

Increase gap between Covishield vaccine doses to 4-8 weeks, Centre tells states
India

Increase gap between Covishield vaccine doses to 4-8 weeks, Centre tells states

This decision to revise the interval between doses from 4-6 weeks is applicable only to Covishield and not to Covaxin, the Union health ministry said